Vaccine Trials

RV 172

“A phase I/II clinical trial to evaluate the safety and immunogenicity of a multiclade HIV-1 DNA plasmid vaccine boosted by a multiclade HIV-1 recombinant adenovirus-5 vector vaccine in HIV uninfected adult volunteers in East Africa”

Purpose

The objectives of the study were to evaluate the safety and immunogenicity of a multiclade A, B and C HIV DNA prime (VRC-HIVDNA016-00-VP) boosted with a multiclade A, B and C recombinant Adenovirus type 5 vector (VRC-HIVADV014-00-VP). The vaccine was provided by the NIH Vaccine Research Center (VRC) consisting of a multiclade A, B and C HIV DNA prime (VRC-HIVDNA016-00-VP) boosted with a multiclade A, B and C recombinant Adenovirus type 5 vector (VRC-HIVADV014-00-VP).

Team: Leonard Maboko (Principal Investigator), Mirjam Schunk, Arne Kroidl (Clinical Research Coordinator)

You can reach us at:

NIMR - Mbeya Medical Research Center
P.O Box 2410
Hospital Hill rd, Mbeya Tanzania

Tel +255 25 250 3364
Fax +255 25 250 3134

Working hours:
Mon - Fri
08:00 - 17:00 EAT (GMT + 3)

Or send us an email at This email address is being protected from spambots. You need JavaScript enabled to view it.

Our Twitter Feed

NIMRMbeya Miaka miwili ya Mhe. Dkt. Samia S. Hassan madarakani 🇹🇿 Tunakupongeza kwa uongozi thabiti na #kaziiendelee 👏… https://t.co/wpKYeKzJZO
22h • reply • retweet • favorite
NIMRMbeya RT @wizara_afyatz: Kutoka Songwe Machi 17, 2023 Kamati ya Kudumu ya Bunge ya Afya na mambo ya UKIMWI imeendelea na ziara ya kukagua maend…
Mar 18 • reply • retweet • favorite
NIMRMbeya RT @iasociety: Mentoring the #NextGeneration—During Day 2 of the #HIVVaccineScienceAcademy all participating young researchers and scientis…
Mar 18 • reply • retweet • favorite
NIMRMbeya RT @NIMRTanga: 📢New publication @Lancet ! "Monthly IPTp with DP did not improve pregnancy outcomes, and the addition of a single course of…
Mar 18 • reply • retweet • favorite
NIMRMbeya RT @NIMR_Tanzania: Delegates from Kampala International University (KIU-Uganda) paid a courtesy call to NIMR DG and discussed areas for res…
Mar 18 • reply • retweet • favorite
© 2017 NIMR - Mbeya Medical Research Center